Why the study?
Atrial fibrillation causes hemodynamic impairment and thromboembolic events leading to significant morbidity, mortality, and cost, necessitating guidelines for optimum management.
This document provides the 2006 ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation.
Answers are grounded in this paper and cite their sources.
Informs optimal AF management now; extends prior recommendations with major society consensus.
Atrial fibrillation (AF) is the most common sustained cardiac rhythm disturbance, increasing in prevalence with age. AF is often associated with structural heart disease, although a substantial proportion of patients with AF have no detectable heart disease. Hemodynamic impairment and thromboembolic events related to AF result in significant morbidity, mortality, and cost. Accordingly, the American College of Cardiology (ACC), the American Heart Association (AHA), and the European Society of Cardiology (ESC) created a committee to establish guidelines for optimum management of this frequent and complex arrhythmia.
No takes yet. Share an insight, caveat, or question.
A 2019 study conducted a review in Atrial fibrillation. Guidelines for the management of patients with atrial fibrillation was evaluated. The ACC, AHA, and ESC established updated clinical practice guidelines for the optimum management of patients with atrial fibrillation.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: